Christophe De Jaeger

127, Rue De La Faisanderie, 
Paris, FR 
127, Rue De La Faisanderie, 
Paris, FR 

Overview

Christophe De Jaeger practices practicing medicine in Paris, France.

His clinical expertise encompasses Secondary Immunodeficiency (SID), Mixed Connective Tissue Disease, Myositis, and Antisynthetase Syndrome.

He is actively involved in clinical research, co-authoring 6 peer reviewed articles.

Gender

Male

Locations

127, Rue De La Faisanderie, Paris, 75016, France

Frequently Asked Questions about Christophe De Jaeger

Is Christophe De Jaeger a top-rated expert for Secondary Immunodeficiency (SID)?

MediFind is an objective health platform that identifies experts based on real-world data. Christophe De Jaeger is classified as an Experienced expert for Secondary Immunodeficiency (SID), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christophe De Jaeger participate in research or clinical trials?

Yes. Christophe De Jaeger has published 6 articles and abstracts on conditions like Secondary Immunodeficiency (SID). You can view a list of Christophe De Jaeger's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De Jaeger's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile